INTROGEN THERAPEUTICS, INC. PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • December 14th, 2006 • Introgen Therapeutics Inc • Pharmaceutical preparations
INTROGEN THERAPEUTICS, INC., a Delaware corporation (the “Company”), proposes to sell to the Investors (defined below), pursuant to the terms of this Placement Agent Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the Investors identified in the Subscription Agreements (each a “Investor” and, collectively, the “Investors”), an aggregate of up to 4,986,500 shares of Common Stock, $0.001 par value (the “Common Stock”), of the Company. The aggregate of up to 4,986,500 shares so proposed to be sold is hereinafter referred to as the “Stock.” The Company hereby confirms its agreement with Mulier Capital Limited as the placement agent for the sale of the Stock to the Investors (the “Placement Agent”).
